课题基金 / 基金详情

Mechanisms of DNA Single-Strand Break-Induced Genetic Disease and Opportunities for Therapeutic Intervention

Mechanisms of DNA Single-Strand Break-Induced Genetic Disease and Opportunities for Therapeutic Intervention
DNA单链断裂诱发遗传病的机制及治疗干预的机会
批准号:
MR/W024128/1
负责人:
Keith Caldecott
金额:
$277.79万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Keith Caldecott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
My laboratory is focused on understanding how breaks in the genetic material (DNA) can lead to disease. The proposed work will address exciting new hypotheses that have arisen during my current research programme concerning the mechanism/s by which unrepaired DNA single-strand breaks (SSBs), which are breaks in one strand of the DNA double helix, trigger neurodegeneration. To date, six human genetic diseases have been identified in which there is a defect in SSB repair; the latest one being identified under the auspices of my current MRC research programme (spinocerebellar ataxia autosomal recessive 26; SCAR26, which is mutated in the protein, XRCC1). Excitingly, we have discovered how unprepared SSBs trigger this disease, providing not only the first molecular explanation for how SSBs cause disease but also opening up possible new avenues for therapeutic intervention. We plan to pursue these novel discoveries in the new research programme proposed here. We will employ a combination of molecular, cellular, and physiological experimental models to build on our recent discoveries and define at the mechanistic level how SSBs cause defects in neuronal function in vitro and in vivo, and how such defects lead to neurological disease. Importantly, we will also continue to develop our work in a clinical direction, by testing the ability of existing and novel drugs/drug-like molecules for their ability to restore normal neuron function and prevent neurological diseases that arise from SSBs. Whilst we are focusing on experimental models of rare genetic diseases to address our scientific questions, the relevance of this work may extend to more common degenerative diseases and even to the normal ageing population. This is because SSBs are the commonest form of DNA damage arising in cells and are induced not only by oxidative stress (which is elevated in brain and is believed to contribute to human ageing) but as discovered in our recent work also by the normal processes by which human neurons regulate the expression of their genes.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-022-32763-6
发表时间: 2022-08-26
期刊: Nature communications
影响因子: 16.6
作者: []
通讯作者:
DOI: 10.1038/s41588-021-01001-y
发表时间: 2022-02-10
期刊: NATURE GENETICS
影响因子: 30.8
作者: [Caldecott, Keith W., Ward, Michael E., Nussenzweig, Andre]
通讯作者: Nussenzweig, Andre
DOI: 10.1002/mgg3.2295
发表时间: 2024-01
期刊: Molecular genetics & genomic medicine
影响因子: 2
作者: []
通讯作者:
DOI: 10.1007/s00439-023-02589-3
发表时间: 2023-09
期刊: Human genetics
影响因子: 5.3
作者: []
通讯作者:
Cellular and Pathological Responses to Chromosome DNA Single-Strand Breaks
  • 批准号:
    MR/P010121/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $258.03万
  • 财政年份:
    2017
  • 负责人:
    Keith Caldecott
  • 依托单位:
Amyotrophic Lateral Sclerosis and the DNA Damage Response
  • 批准号:
    MR/K01854X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $45.86万
  • 财政年份:
    2013
  • 负责人:
    Keith Caldecott
  • 依托单位:
Chromosomal Single-Strand Break Repair: Mechanisms and Degenerative Disease
  • 批准号:
    MR/J006750/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $266.12万
  • 财政年份:
    2012
  • 负责人:
    Keith Caldecott
  • 依托单位:
Characterisation of a Novel Human Tyrosyl DNA phosphodiesterase
  • 批准号:
    G0901606/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $46.41万
  • 财政年份:
    2010
  • 负责人:
    Keith Caldecott
  • 依托单位:
国内基金
海外基金
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
  • 批准号:
    2026JJ50413
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王东亮
  • 依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
  • 批准号:
    2026JJ60135
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨思慧
  • 依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: